Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03519555 · ClinicalTrials.gov registry record
BIOSURE™ RG Knee Safety & Performance Study
A clinical trial, sponsored by Smith & Nephew.
- Completed
- Registry status
- 60
- Enrollment target
NCT03519555: Completed study, sponsored by Smith & Nephew.
NCT03519555 is a clinical trial that has completed, run by Smith & Nephew. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03519555 has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Safety and Performance of the BIOSURE™ REGENESORB Interference Screw in Knee Ligament Repair and Reconstruction
Primary Outcome
Survival rate at 6 months
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-11-09 |
| Est. Completion | 2020-10-05 |
What the finished NCT03519555 record still lists
NCT03519555 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03519555 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03519555 about?
NCT03519555 is a clinical study titled "BIOSURE™ RG Knee Safety & Performance Study". Safety and Performance of the BIOSURE™ REGENESORB Interference Screw in Knee Ligament Repair and Reconstruction
What is the current status of trial NCT03519555?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2017-11-09. Estimated completion is 2020-10-05.
Who is sponsoring clinical trial NCT03519555?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI